Targeted therapy in cancer and transgenic animal model.
Inui
Akio
A
D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000494:pharmacology; D001549:Benzamides; D001943:Breast Neoplasms / Q000188:drug therapy; D018890:Chemoprevention; D004195:Disease Models, Animal; D018734:Genes, erbB-2; D006801:Humans; D000068877:Imatinib Mesylate; D051379:Mice; D008822:Mice, Transgenic; D009369:Neoplasms / Q000188:drug therapy*; D010879:Piperazines / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D015398:Signal Transduction; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D000068878:Trastuzumab